Navigation Links
Transvaginal Mesh Lawyers at Bernstein Liebhard LLP Note New Order in New Jersey C.R. Bard Litigation Concerning Handling of Explants and Tissue Samples
Date:6/17/2013

New York, New York (PRWEB) June 17, 2013

Lawsuits involving alleged transvaginal mesh complications associated with products manufactured by C.R. Bard, Inc. continue to move forward in a Multicounty Litigation now underway in New Jersey’s Atlantic County Superior Court, Bernstein Liebhard LLP reports. On May 31st, the Court issued a new Consent Order that set forth protocols for the preservation and testing of explanted devices and tissue samples for the litigation’s bellwether cases. Court documents indicate that the first of those bellwether cases will begin going to trial on September 23, 2013. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10)

“This Order will ensure that medical evidence important to plaintiffs’ claims is properly preserved. We are pleased to see that the C.R. Bard transvaginal mesh lawsuits pending in New Jersey are moving forward, and look forward to the start of the proceeding’s first trials,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm’s transvaginal mesh lawyers continue to offer free legal consultations to women who allegedly suffered serious complications following implantation of devices manufactured by C.R. Bard, Inc., as well as American Medical Systems, Inc., Ethicon, Inc. and Boston Scientific Corp. Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving as Co-Liaison Counsel in the C.R. Bard litigation underway in New Jersey.

Transvaginal Mesh Complications
In July 2011, the U.S. Food & Drug Administration (FDA) revealed that it had received more than 3,800 reports of serious complications involving transvaginal mesh products between 2005 and the end of 2010. The agency also changed its position regarding the frequency of such injuries in pelvic prolapse repair, declaring it no longer
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related medicine news :

1. US Drug Watchdog Launches Now Calls Transvaginal Mesh A Disaster For 100,000's of US Women Recipients And Offers The Names and Contacts Of The Best Women Attorneys
2. Johnson & Johnson Violated FDA Order to Halt Sales of Transvaginal Mesh
3. US Drug Watchdog Now Fears the Numbers of Transvaginal Mesh Product Failure Victims Will Grow and They Offer Victims the Names of the Best Lawyers-Who Will All Be Women
4. US Drug Watchdog Now Urges Transvaginal Mesh, Tape Or Sling Failure Victims To Call Them For The Names Of The Best Possible Attorneys-Who Are All Also Women-Get Help Now
5. US Drug Watchdog Now Offers All Victims Of A Transvaginal Mesh, Sling, or Tape Failure The Names And Contacts Of The Best Possible National Caliber Lawyers Who Are Women
6. US Drug Watchdog Expands Their Transvaginal Mesh Initiative Because Of The Potential Number Of Victims & They are Offering the Names of the Best Women Attorneys To Help
7. Transvaginal Mesh Lawsuit Update: New Study Concerning Use of Vaginal Mesh in Prolapse Procedures, Bernstein Liebhard LLP Reports
8. US Drug Watchdog Now Urges All Victims of a Transvaginal Sling, Tape, or Mesh Failure to Call Them for the Names of National Caliber Women Attorneys-Get Help Now
9. Wright & Schulte LLC Files Transvaginal Mesh Lawsuit on Behalf of Woman Allegedly Injured by Align Urethral Support System
10. US Drug Watchdog Now Offers Women Who Are Victims Of A Transvaginal Mesh, Sling, or Tape Medical Product Failure the Names of The Best Possible Lawyers-Who are All Women
11. US Drug Watchdog Is Expanding Their Effort To Ensure Victims Transvaginal Sling,Tape,Or Mesh Failure Get The Names And Contacts of Top Caliber Attorneys-Who Are All Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/23/2014)... Fairfax, Va., April 23, 2014 The American Society ... guideline, "The Role of Postoperative Radiation Therapy for ... the use of adjuvant radiation therapy in the ... is published in the May-June 2014 issue of ... clinical practice journal of ASTRO. The full-length guideline ...
(Date:4/23/2014)... compound that targets an important brain receptor has a ... including relapse behavior, a University at Buffalo animal study ... this may be a novel lead compound for treating ... UB research was published as an online preview article ... study, the compound, RO5263397, severely blunted a broad range ...
(Date:4/23/2014)... "simple and accessible detection methods that can rapidly ... of a single cell inside that population has ... Chang Lu. , In the Royal Society of ... announced that he and his coworkers have developed ... of a protein ( Chem. Sci. , 2014, ...
(Date:4/23/2014)... the United States, it may come as a surprise that ... food due to lack of money or other financial resources. ... University of Illinois using data from the National Health and ... dealing with hunger are also facing negative health and nutrition ... age 60 faced the threat of hungerthat translates to 4.8 ...
(Date:4/23/2014)... Occupational and Leisure Time Physical Activity on Mobility Limitation ... midlife increases the risk of mobility limitation in old ... is found in a study which followed up 5,200 ... conducted at the Gerontology Research Center in Finland and ... labor is often repetitive, wears the body and lasts ...
Breaking Medicine News(10 mins):Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 2Health News:ASTRO issues guideline on the role of postoperative radiation therapy for endometrial cancer 3Health News:Novel compound halts cocaine addiction and relapse behaviors 2Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:More Americans in their golden years are going hungry 2Health News:Midlife occupational and leisure-time physical activity limits mobility in old age 2
... technique could pave the way toward screening people at ... may foreshadow malignancies, researchers from the University of Colorado ... in cancer is prevention, said researcher Wilbur A. Franklin, ... Health Sciences Center. Our goal would be to develop ...
... Dr. Peter Farrell to remain Chairman of the Board, ... RMD ),announced today that its board of directors ... the company. Effective January,1, 2008, Kieran T. Gallahue will ... board of directors. Mr. Gallahue, 44, will succeed Dr. ...
... United States,Government, through the U.S. Agency for International ... in equipment and technical,assistance to the Government of ... This announcement follows the provision of an initial ... Hellenic Red Cross for emergency,fire fighting equipment and ...
... members of SEIU UHW-West and 121RN, their, first ... hospital, BURBANK, Calif., Aug. 30 Caregivers at ... United Healthcare Workers -,West (UHW) and SEIU 121RN, reached ... Medical Center. The contract, which expires,Sept. 30, 2011, grants ...
... (ret), former White House National Drug Policy,Director (1996- 2001), ... widely cited terrorism and drug policy expert in the ... State Capitol rally for,recovery and treatment at 11 AM ... speaking will be California HHS Secretary Kimberly Belshe and,State ...
... Company Refuses to Pay Hospital ... Market-Competitive Rates, SAN DIEGO, ... against Blue Shield, the large insurance company,that is attempting to force ... "Blue Shield,s calculated and aggressive negotiating tactics are,designed to break ...
Cached Medicine News:Health News:New technique detects specific chromosomal damage, may indicate lung cancer risk 2Health News:ResMed Names Kieran Gallahue as Chief Executive Officer, Effective January 1, 2008. 2Health News:Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract 2Health News:4-Star Gen. Barry Mccaffrey, Former U.S. Drug Czar, to Keynote 'Recovery Happens!' Rally for Treatment: Wed., Sept. 5, 11 Am, State Capitol West Steps, Sacramento 2Health News:Alvarado Hospital Files Countersuit Against Blue Shield 2Health News:Alvarado Hospital Files Countersuit Against Blue Shield 3
(Date:1/15/2014)... , Jan. 15, 2014 Massachusetts General Hospital ... AMGN ) announced today that they have ... validate new therapeutic targets and develop novel therapies ... that affects millions worldwide. The MGH-Broad-Amgen collaboration brings ...
(Date:1/15/2014)... 2014  Manufacturers, suppliers and distributors of innovative medical-related ... their most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the ... the most litigious industry sectors of cases involving ...
(Date:1/15/2014)... Inc. (Nasdaq: ECTE ) ("Echo"), a medical ... non-invasive, wireless continuous glucose monitoring system, today announced that ... CEO of Echo Therapeutics, will present at "TEN", Noble ... Mr. Doman will make a corporate presentation to ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Intellectual Property Insurance for Medical-related Products and Services 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
Ultrasonic Pachymeter UP-1000 is fast, accurate corneal thickness measurements....
... pachymeter, with large high resolution LCD touch ... 300P is a portable, digital pachymeter which ... of a high frequency, low noise probe ... immediately upon application of the probe along ...
... pachymeter, with compact LCD screen and optional ... portable, weighing slightly more than 2 lbs ... large liquid crystal display. The combination of ... fast precise algorithm enables measurement immediately upon ...
... mounted on a stick to make ... are 37 mm square. They are ... 50PD. Plus red square. Now shipping ... prism on stainless steel stick. Specify ...
Medicine Products: